Pharmaceuticals: Value chain, from upstream to the customer
Drug discovery, manufacturing and distribution, from small-molecule generics to biologics
Value chain, from upstream to the customer
Criticality to the chain: 5 · Chokepoint 4 · Critical 3 · Important 2 · Supporting 1 · Commodity service Stage 1 Discovery and developmentDiscover new molecules, run clinical trials and hold the patents and approvals that let them sell branded medicines at a premium for about a decade.1
Why critical: New medicines come from a few dozen large firms and many venture-funded biotechs, the US takes 74% of sales of medicines launched in 2020-241, and a patented drug has no substitute until generics arrive. Technologies Target biology and genomics Medicinal chemistry and AI-assisted design Monoclonal antibodies GLP-1 and peptide drugs Cell and gene therapy Depends on Chemicals Rgt Reagents and high-purity lab chemicalsPep Peptides and oligonucleotidesChi Chiral and specialty building blocks Energy Bld Energy in buildingsDC Data centres Industries Education and researchFinance: banking, insurance, marketsSoftware and IT servicesExamples: Eli Lilly, Novo Nordisk, Roche, Merck & Co., Zydus LifesciencesRun preclinical studies and clinical trials, and handle data and regulatory filings for drug developers.
Why important: Several large global CROs and many regional ones exist, but switching mid-trial costs months. Technologies Clinical trial management systems Bioanalytical labs Electronic data capture Real-world evidence analytics Depends on Chemicals Rgt Reagents and high-purity lab chemicals Energy Bld Energy in buildings Industries Healthcare servicesSoftware and IT servicesExamples: IQVIA, ICON, Syngene International, Veeda Clinical ResearchMake the fine chemicals and fermentation products (KSMs, intermediates, 6-APA, 7-ACA) from which APIs are synthesised.4,6
Why chokepoint: Nearly three-quarters of India's API and intermediate imports by value come from China, and for antibiotics such as penicillin there is no near-term alternative; India's PLI scheme had built capacity for only 25 APIs, KSMs and intermediates by March 20254,6. Technologies Multi-step organic synthesis Large-scale fermentation Continuous flow chemistry Solvent recovery Depends on Commodities Su SugarMz Maize Chemicals KSM Pharma starting materials and intermediates6APA Antibiotic intermediates (6-APA, 7-ACA)MeOH MethanolTol TolueneAcOH Acetic acidHCl Hydrochloric acid Energy Tc Thermal coalBlr Boilers, furnaces and stoves Industries Water and sanitationExamples: Zhejiang Huahai Pharmaceutical, Shandong Xinhua Pharmaceutical, Aarti Pharmalabs, Aurobindo Pharma (penicillin G)Supply the binders, fillers, coatings and empty capsules that turn an API into a tablet or capsule.
Why important: Several qualified suppliers exist, but changing an excipient source needs regulatory variation filings. Technologies Microcrystalline cellulose production Film-coating systems Gelatin and HPMC capsules Spray drying Depends on Commodities Tm TimberMz Maize Chemicals Exc Pharmaceutical excipientsStr Starch and cellulose derivativesTiO2 Titanium dioxideGlyc Glycerine Energy HI Energy-intensive industryExamples: Roquette, Colorcon, ACG Worldwide, Sigachi IndustriesSynthesise active pharmaceutical ingredients to GMP standards for their own formulations or under contract for innovators and generic firms.
Why critical: Each approved API source is named in the drug filing, so replacing one needs new validation batches and a regulatory variation, typically a year or more (estimate). Technologies cGMP multipurpose reactors Crystallisation and milling High-potency containment Process analytical technology Depends on Chemicals API Small-molecule APIsKSM Pharma starting materials and intermediatesCDMO Custom synthesis (CDMO)N2 Nitrogen gasIPA Isopropanol Energy Blr Boilers, furnaces and stovesHP Heat pumps, air conditioning and refrigerationDist Distribution grids, mini-grids and interconnectors Industries Water and sanitationMachinery and equipmentExamples: Divi's Laboratories, Laurus Labs, Lonza, WuXi AppTec, SiegfriedGrow cells or microbes in bioreactors to make antibodies, insulin, vaccines and biosimilars, for themselves or as contract makers.
Why critical: Large-scale bioreactor capacity sits with a few firms in Korea, Switzerland, China and India, and tech transfer takes over a year. Technologies Mammalian cell culture Single-use bioreactors Chromatography purification Fill-finish in isolators Cold-chain release testing Depends on Commodities Su Sugar Chemicals Lys Amino acids (lysine, methionine)Pep Peptides and oligonucleotidesPP PolypropyleneCO2 Carbon dioxide Energy HP Heat pumps, air conditioning and refrigerationDist Distribution grids, mini-grids and interconnectors Industries Water and sanitationPlastic and rubber productsExamples: Samsung Biologics, Lonza, Serum Institute of India, Biocon BiologicsTurn APIs into tablets, injectables and inhalers, file dossiers with regulators and sell to wholesalers, hospitals and governments.3
Why important: Most generics have several approved makers, but sterile injectables have few, causing recurring shortages. Technologies Granulation and tableting Sterile injectables Modified-release formulations Bioequivalence studies Serialisation Depends on Chemicals API Small-molecule APIsExc Pharmaceutical excipientsAPAP Paracetamol Energy HP Heat pumps, air conditioning and refrigerationDist Distribution grids, mini-grids and interconnectors Industries Paper and packagingWater and sanitationMachinery and equipmentExamples: Sun Pharmaceutical, Cipla, Dr. Reddy's Laboratories, Teva, SandozMake glass vials, syringes, blister films, foil and stoppers that touch the drug and keep it sterile and stable.
Why critical: Pharma-grade borosilicate tubing comes from very few producers, a bottleneck exposed in the Covid vaccine rollout. Technologies Type I borosilicate glass tubing Prefillable syringes Cold-form aluminium blisters Elastomer stoppers Depends on Commodities Qz Silica sandB BoronAl Aluminium Chemicals PVC PVCSil SiliconesPP Polypropylene Energy Gas Natural gasHI Energy-intensive industry Industries Plastic and rubber productsPaper and packagingExamples: Schott, Gerresheimer, West Pharmaceutical Services, Schott Poonawalla, ACG WorldwideApprove medicines, inspect plants against GMP, set quality standards and recall unsafe products; approval is the licence to sell.
Why chokepoint: There is one regulator per market; a US FDA warning letter or import alert can cut a plant off from its largest market overnight. Technologies Dossier review (CTD) GMP inspections Pharmacovigilance Pharmacopoeial monographs Depends on Chemicals Rgt Reagents and high-purity lab chemicals Energy Bld Energy in buildings Industries Public administration, defence and securityExamples: US FDA, European Medicines Agency, CDSCO, Indian Pharmacopoeia CommissionBuy from manufacturers and deliver many times a day to pharmacies and hospitals, handling cold chain, credit and returns.
Why important: Three firms dominate US wholesale, while India has a fragmented network of stockists that is easy to switch but hard to bypass. Technologies Temperature-controlled warehouses Track-and-trace serialisation Demand forecasting B2B ordering apps Depends on Energy PCM Latent heat and cold storageICV Combustion road vehicles Industries Transport and logisticsWholesale and retail tradeExamples: McKesson, Cencora, Cardinal Health, Entero Healthcare SolutionsDispense medicines to patients on prescription or over the counter, and advise on use.
Why supporting: Hundreds of thousands of outlets compete; patients can switch pharmacies at once. Technologies Pharmacy management software E-prescriptions Online ordering and delivery Generic substitution (Jan Aushadhi) Depends on Energy Bld Energy in buildings Industries Healthcare servicesE-commerce and digital marketplacesExamples: Apollo Pharmacy, MedPlus, CVS Health, Tata 1mg, Jan Aushadhi Kendras